• Guard Therapeutics will complete its transition into Disruptive Pharma with an opening-bell ceremony at Nasdaq Stockholm on Aug. 21, 2026.
• Shares start trading under new ticker DPHA on Aug. 21, replacing GUARD, while remaining listed on Nasdaq First North Growth Market.
• The reverse takeover of Disruptive Pharma Holding was completed on July 27, 2026, shifting the listed group’s operations to Formulite.
• The company’s ISIN will remain unchanged, with no action required from existing shareholders.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guard Therapeutics International AB (publ) published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.